Skip to main content

Want a detailed portfolio tracker?

Clearside Biomedical, Inc. Common Stock (CLSD) P/E (2016 - 2026)

Clearside Biomedical, Inc. Common Stock (CLSD) P/E from Sep 30, 2016 to Jul 21, 2026. The TTM Clearside Biomedical, Inc. Common Stock (CLSD) P/E is -0.08. You can export chart.

P/E

Annual P/E change of Clearside Biomedical, Inc. Common Stock (CLSD)

YearP/EChange
2026-0.08N/A
2025-0.08-96.00%
2024-2.01+4.88%
2023-1.92-87.18%
2022-14.97-97.70%
2021-651.10+9329.19%
2020-6.91+103.52%
2019-3.39+761.26%
2018-0.39-89.00%
2017-3.58-88.97%
2016-32.48N/A

Comparison Clearside Biomedical, Inc. Common Stock (CLSD) P/E with competitors

Clearside Biomedical, Inc. Common Stock (CLSD) P/E is -0.08.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-102.11%
NBYStablecoin Development Corp0.00-105.34%
ENLVEnlivex Ltd0.07-192.94%
FGENFibroGen Inc0.24-398.25%
CHRSCoherus Biosciences Inc0.85-1154.30%
FBIOFortress Biotech Inc0.95-1279.18%
ORMPOramed Pharmaceuticals Inc1.50-1967.55%
AGENAgenus Inc3.01-3839.45%
INVAInnoviva Inc3.15-4018.87%
VXRTVaxart Inc3.55-4510.55%
CRMDCorMedix Inc3.63-4608.34%
CVACCureVac N.V.4.45-5623.75%
GLPGGalapagos NV4.86-6137.17%
SRPTSarepta Therapeutics Inc4.88-6165.99%
ABEOAbeona Therapeutics Inc5.39-6793.98%
ABUSArbutus Biopharma Corp5.60-7052.55%
ZVRAZevra Therapeutics Inc5.89-7414.88%
SPROSpero Therapeutics Inc6.23-7838.83%
CGENCompugen Ltd6.31-7945.07%
RIGLRigel Pharmaceuticals6.87-8638.54%
SLXNSilexion Therapeutics Corp7.30-9165.38%
OMEROmeros Corporation9.26-11604.00%
AUPHAurinia Pharmaceuticals Inc9.58-12009.32%
PLXProtalix BioTherapeutics Inc10.89-13632.09%
ACADAcadia Pharmaceuticals Inc11.73-14672.72%
TBPHTheravance Biopharma Inc12.26-15335.75%
ADMAAdma Biologics Inc12.42-15529.58%
HRMYHarmony Biosciences Holdings Inc13.82-17271.64%
SABSSAB Biotherapeutics Inc14.14-17664.28%
NAGENiagen Bioscience Inc14.82-18511.57%
INCYIncyte Corp15.82-19759.59%
REGNRegeneron Pharmaceuticals Inc15.86-19801.96%
PBYIPuma Biotechnology Inc17.32-21614.84%
CPRXCatalyst Pharmaceuticals Inc17.44-21768.41%
EXELExelixis Inc17.54-21891.05%
TGTXTG Therapeutics Inc18.97-23665.41%
MDXGMimedx Group Inc20.55-25636.59%
XOMAXOMA Royalty Corp22.87-28522.66%
ARGXArgen X SE24.30-30291.17%
CTMXCytomX Therapeutics Inc24.82-30941.15%
XOMAOXOMA Royalty Corp25.34-31591.87%
HALOHalozyme Therapeutics Inc25.62-31938.42%
XOMAPXOMA Royalty Corp25.67-31996.07%
VRTXVertex Pharmaceuticals Inc27.99-34884.50%
RPRXRoyalty Pharma plc - Class A28.69-35745.34%
SLNOSoleno Therapeutics Inc29.02-36152.64%
ASNDAscendis Pharma A/S30.09-37482.42%
LGNDLigand Pharmaceuticals Inc - Class B37.91-47207.09%
APLSApellis Pharmaceuticals Inc39.02-48585.33%
BMRNBiomarin Pharmaceutical Inc42.21-52549.80%
KRYSKrystal Biotech Inc45.34-56440.96%
ONCBeiGene Ltd69.54-86506.64%
PHARPharming Group N.V.75.03-93322.13%
TECHBio-Techne Corp101.96-126787.17%
VCELVericel Corp109.92-136681.45%
ALNYAlnylam Pharmaceuticals Inc117.96-146676.13%
GMABGenmab140.29-174416.63%
TLXTelix Pharmaceuticals Ltd162.15-201581.08%
CORTCorcept Therapeutics Inc212.86-264583.59%